Dr. Agarwal’s Health Care Shares Drop 7% Today After Announcing 23:2 Merger Swap Ratio with AEHL

Chennai, August 28, 2025 – Shares of Dr. Agarwal’s Health Care Limited (NSE: AGARWALEYE, BSE: 544350) had a drastic graph during Thursday’s session as it hit an intraday high and low of 8.07% and 6.93%, respectively, so far. The volatile movement in the company’s stock came after it made an announcement that it would undergo a merger with Dr. Agarwal’s Eye Hospital Limited.

Dr. Agarwal’s Health Care is a leading eye-care chain in India, recognised for its strong presence in ophthalmology services. Headquartered in Chennai, the company operates across multiple regions with a growing network of hospitals and clinics. Operating in the healthcare industry, it focuses on advanced eye treatments and surgeries. Its shares are listed on the BSE under the ticker AHCL.

Market Snapshot

As of August 28, 2025, 02:15 PM IST, shares of Dr. Agarwal’s Health Care were trading at ₹437.90, down 4.79% from the previous close. Despite the volatility, volumes remained robust at 14.3 lakh shares with a traded value of ₹62.71 crore, and delivery percentage stood strong at 83.79%, reflecting significant investor participation. The stock’s elevated P/E above 175 highlights expensive valuations, while its proximity to the recent 52-week high of ₹494.50 underscores heightened volatility within the hospital sector.

Merger Highlights

The proposed merger between Dr. Agarwal’s Health Care Limited (AHCL) and Dr. Agarwal’s Eye Hospital Limited (AEHL) will have a swap ratio of 2:23 (AEHL: AHCL), where for every two equity shares of ₹10 each in AEHL, shareholders will receive 23 equity shares of Re. 1 each in AHCL. There will also be a preferential issue by AEHL, where it will raise ₹70 crore through 1,32,827 equity shares at ₹5,270 apiece, which is equal to 2.7% of its equity base.

Dr. Adil Agarwal, CEO of AHCL, called the merger “a long-awaited step” that will “unlock the full potential of the combined businesses” while simplifying group structure and enhancing long-term shareholder value.

Outlook And Investor Takeaway

The announcement of the merger has triggered volatility in how the shares of Dr. Agarwal’s Health Care are performing on the stock exchange. The company’s valuation is already appearing stretched, particularly given its elevated price-to-earnings ratio. While the merger between AEHL and AHCL is expected to simplify operations for the merged entity with enhanced synergy, investors should keep an eye out for how the combined entity manages execution risks, regulatory clearances, and post-merger financial performance.

REF: https://nsearchives.nseindia.com/corporate/DRAGARWALS_27082025192523_SE_PressRelease.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations